The China Challenge to U.S. Biopharma

The China Challenge to U.S. Biopharma Marc Pentopoulos, of Vista Point Capital, who manages the biotech portion of the Palumbo Emerging Growth strategy, published what we think is an important report discussing the evolution of Chinese competition with the biopharma industry. Here is a summary of his comments: Chinese biotech companies have largely caught up […]